Tag Archives: announces

World Coffee Alliance (WCA) announces confirmed speakers at WCA CROSS TALK SERIES 2021 Virtual Event – “Digitalising Access to Coffee Finance: Where is the Beef?”

LONDON, United Kingdom – World Coffee Alliance (WCA), a network alliance of coffee industry professionals producing critical insights including market research, due diligence reports and technical advice in the global coffee value chain will hold a Zoom virtual event WCA CROSS TALK SERIES – “Digitalising Access to Coffee Finance: Where is the Beef?” on Wednesday… Read More »

Confirmit announces intention to merge with FocusVision

London, UK, Oslo, Norway and New York, NY, 7th January 2021 – Confirmit, a leading provider of solutions that enable Market Research, Customer Experience and Employee Engagement teams to turn insights into stories that fuel action, announced today its intention to merge with FocusVision, a leading provider of customer insights technology. The merger is conditioned… Read More »

HIMSS announces August date for 2021 annual global conference

HIMSS has rescheduled its annual global conference from March 2021 to August 2021, due to safety concerns over the COVID-19 pandemic. The 2021 HIMSS Global Health Conference & Exhibition is officially moving to August 9-13 in Las Vegas, making it about 29 months between the usual annual event, HIMSS President and CEO Hal Wolf said during… Read More »

KemPharm Announces FDA Approval of sNDA for Two Additional Strengths of Apadaz (4.08 mg benzhydrocodone/325 mg APAP and 8.16 mg benzhydrocodone/325 mg APAP)

Print this page CORALVILLE, Iowa, Jan. 07, 2019 (GLOBE NEWSWIRE) — KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug Application (sNDA) for two additional strengths of Apadaz, an immediate release (IR)… Read More »

FDA announces recall of another heart medicine for possible cancer risk

The recalled lot will have “Westminster Pharmaceuticals” and “GSMS Inc.” on the label, according to the FDA list. Another heart medicine, valsartan, has also been recalled recently due to contamination. Irbesartan is an angiotensin II receptor blocker, or ARB. This is a drug that blocks a potent chemical in the blood called anigiotensin, which causes… Read More »